obesity drug news today glp-1 october 2025 therapies are changing care. What does WHO recommend? Here's what you need to know 1 in 10 Americans Has

15 How do I use Saxenda

As prices become more affordable, these drugs could transform chronic disease management for millions

But if I see someone who's lived with obesity for a long period of time, like years as we said, years living with obesity I'm going to pay very close attention to them about their disease risk

Just like Ozempic, Wegovy is given as a subcutaneous injection once a week, under the skin of the stomach, thigh, or upper arm

I think that's likely, if anything, because what we've seen is the demand for GLP-1s is only increasing, and branded oral formulations of these medications are still more than a year away," he noted

ShapiroWilk test was used to check the normality of the variable distribution